INS and acute myeloid leukemia: We investigated the effects of metabolic inhibitors on in vitro AML cell proliferation for a consecutive and thus unselected subset of 48 patients; 16 patients showed a general increase in pathway activation in response to insulin (Fig. 1, subcluster I), and 32 patients showed a diverse response (clusters II–IV).